AIDS Malignancies Training and Research International Program (AMTRIP)

艾滋病恶性肿瘤培训和研究国际计划 (AMTRIP)

• 批准号: 10542913
• 负责人: Chipepo Kankasa
• 金额: $ 28.71万
• 依托单位: LSU HEALTH SCIENCES CENTER
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-02-01 至 2026-03-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10542913
• 关键词: AIDS; Malignancies; Training; Research; International

PROJECT SUMMARY/ABSTRACT HIV/AIDS is at epidemic proportions in Zambia, where approximately 1.2 million people – representing about 12% of the country's adult population – are infected. Concomitant with this epidemic, the widespread availability of free anti-retroviral treatment in-country has increased the lifespan of HIV-1 infected individuals, resulting in prolonged chronic immunosuppression and increased occurrence of HIV-associated cancers. However, in-country efforts to prevent, diagnose, and manage cancer in Zambia have been hindered by a lack of laboratory facilities, insufficient cancer research infrastructure, and a shortage of trained personnel. Recognizing these critical gaps, the University of Zambia School of Medicine, the University Teaching Hospitals, and the University of Nebraska-Lincoln leveraged the success of a previous Fogarty partnership to establish the AIDS Malignancies Training and Research International Program (AMTRIP) in collaboration with a new lead partner, the Cancer Diseases Hospital (CDH). This unique program aims to enhance Zambia's cancer research infrastructure and capacity by training Zambian biomedical researchers and health care providers in laboratory techniques and research methodology related to basic cancer biology, molecular genomics, and bioinformatics. Now in its fifth year, AMTRIP has made significant strides by providing intensive long-term graduate degree training and short- and medium-term technical training for a diverse group of 25 trainees; hosting workshops for over 300 health care professionals; successfully transitioning trainees into mentorship roles; adapting program activities to meet the needs of trainees and the rapidly changing cancer research landscape; and leveraging partnerships with other D43 programs to expand the program's impact. Building on these accomplishments, this renewal application seeks to further enhance cancer research capacity in Zambia by: 1) continuing to provide long-term academic instruction and research experiences for eight current master's and three current PhD students in Zambia and recruiting four additional master's and two additional PhD students; 2) providing medium-term (six months to one year) technical training for trainees in topics related to molecular pathology, cancer biology, bioinformatics and genomics; and 3) delivering short- term training (less than three months) and technical workshops (3-5 days) designed to enhance basic, clinical, implementation, genomics, bioinformatics, and behavioral cancer research in collaboration with other regional partners and programs. Expected outcomes of this renewal include the graduation of eight current master's and three current PhD candidates; recruitment and training of an additional four master's and two PhD students in relevant cancer research fields; the transition of trainees into mentorship roles; enhanced infrastructure at Zambian institutions, including the completion of a CDH laboratory renovation; and expanded partnerships with other D43 programs. Given current progress and anticipated renewal outcomes, AMTRIP is on track to transition program leadership to the next generation of cancer researchers in a future renewal.

项目总结/摘要 艾滋病毒/艾滋病在赞比亚已达到流行病的程度，该国约有120万人， 全国12%的成年人被感染。伴随着这一流行病， 国内免费提供抗逆转录病毒治疗延长了HIV-1感染者的寿命， 导致长期的慢性免疫抑制和HIV相关癌症的发生率增加。 然而，赞比亚国内预防、诊断和管理癌症的努力因缺乏 实验室设施不足，癌症研究基础设施不足，训练有素的人员短缺。 认识到这些关键差距，赞比亚大学医学院，大学教学 医院和内布拉斯加大学林肯分校利用之前福格蒂合作的成功， 建立艾滋病防治培训和研究国际计划（AMTRIP），与 一个新的主要合作伙伴，癌症疾病医院（CDH）。这一独特的计划旨在加强赞比亚的 通过培训赞比亚生物医学研究人员和卫生保健， 提供与基础癌症生物学、分子生物学和生物学相关的实验室技术和研究方法 基因组学和生物信息学。现在是第五个年头，AMTRIP通过提供密集的 长期研究生学位培训和中短期技术培训， 培训生;为300多名卫生保健专业人员举办讲习班;成功地将培训生转变为 指导角色;调整项目活动以满足学员的需求和快速变化的癌症 研究景观;并利用与其他D43计划的伙伴关系，以扩大该计划的影响。 在这些成就的基础上，这一更新申请旨在进一步加强癌症研究 通过以下方式提高赞比亚的能力：1）继续为以下人员提供长期的学术指导和研究经验： 在赞比亚招收8名硕士生和3名博士生，并再招收4名硕士生和 增加两名博士生; 2）为受训人员提供中期（6个月至1年）技术培训 与分子病理学、癌症生物学、生物信息学和基因组学相关的主题;以及3）提供短- 定期培训（少于三个月）和技术讲习班（3-5天），旨在加强基础，临床， 实施，基因组学，生物信息学和行为癌症研究与其他区域合作 合作伙伴和方案。此次更新的预期成果包括八名现任硕士毕业 和三名博士候选人;招聘和培训另外四名硕士和两名博士 相关癌症研究领域的学生;学员过渡到导师角色;加强 赞比亚各机构的基础设施，包括完成CDH实验室的翻新; 与其他D43项目合作。鉴于目前的进展和预期的更新结果， 在未来的更新中，将项目领导权移交给下一代癌症研究人员。